Open AccessSerum triglycerides in Alzheimer disease
Author(s) -
Megan M. Bernath,
Sudeepa Bhattacharyya,
Kwangsik Nho,
Dinesh Kumar Barupal,
Oliver Fiehn,
Rebecca Baillie,
Shan L. Risacher,
Matthias Arnold,
Tanner Y. Jacobson,
John Q. Trojanowski,
Leslie M. Shaw,
Michael W. Weiner,
P. Murali Doraiswamy,
Rima KaddurahDaouk,
Andrew J. Saykin
Publication year - 2020
Publication title -
neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.91
H-Index - 364
eISSN - 1526-632X
pISSN - 0028-3878
DOI - 10.1212/wnl.0000000000009436
Subject(s) - entorhinal cortex , alzheimer's disease neuroimaging initiative , medicine , apolipoprotein e , neurodegeneration , alzheimer's disease , disease , oncology , dementia , gastroenterology , hippocampal formation , pathology , endocrinology , psychology
To investigate the association of triglyceride (TG) principal component scores with Alzheimer disease (AD) and the amyloid, tau, neurodegeneration, and cerebrovascular disease (A/T/N/V) biomarkers for AD.